By Katie Van Syckle “Let’s figure out what our letter of the day is!” Ms. Rachel, the children’s YouTube star, cooed that sentence in an Instagram video posted this week as she dug into a ...

Several disease-modifying therapies (DMTs) can help change the disease course of MS. People with MS can also take other medications for symptoms, complications, and relapses. Multiple sclerosis ...

MS Office branding was iconic, but it is now gone.(Microsoft) With this change, the Office brand is officially gone. However, the branding is somewhat confusing, as Microsoft has opted to use the ...

Solana (SOL) price hit a new all-time high of 0.0936 against Ether (ETH) on Jan. 19 before retracing the current level of 0.0769. SOL’s impressive performance in recent days can be attributed to ...

MEMPHIS, Tenn. — A two-vehicle crash in Marshall County, Mississippi left two people dead on Thursday morning, according to the Marshall County Sheriff’s Office. Officers responded to the ...

A coroner is investigating the death of a grandmother following a heart stress test at a Brisbane hospital which her family believe should never have been given. Yaqin Han, 69, went into cardiac ...

Blood tests are often the first line of testing for evaluating MS symptoms. They can’t confirm a diagnosis of MS, but they can help rule out other conditions or point to a diagnosis. Multiple ...

New Study Finds a Promising Combined Therapy for Multiple Sclerosis Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel ...

Be smitten by this charmer. Watch out for Cupid's arrow! This 4x2 home wastes no time wooing you with its practical charm and sleek modern upgrades. It greets you with a tidy front yard, plentiful ...

Flawlessly crafted with a focus on high end design and modern functionality, this new duplex is a true family entertainer. It basks in a luminous north facing aspect from a tightly held pocket, a ...

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors ...